Hasco Med Inc (HASC) 0.0223 $HASC HASCO Medical Releases

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hasco Med Inc (HASC) 0.0223 $HASC

HASCO Medical Releases Q1 Results
Marketwired - Fri May 15, 9:00AM CDT
HASCO Medical (OTCQB: HASC), a company that conducts sales of wheelchair accessible vans, parts, service and rentals, released their first quarter results yesterday.

HASCO Medical Officers/Directors Purchase Stock During Trading Window
Marketwired - Mon May 11, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a company that conducts sales of wheelchair accessible vans, parts, service and rentals, announces recent insider purchases of stock.

Ride-Away Is First Dealership in America Where the Public Can Experience the New BraunAbility MXV
Marketwired - Mon Apr 13, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a company that conducts sales of wheelchair accessible vans, parts, service and rentals, announces the Grand Opening of the new Parkville, Maryland Ride-Away(R) location April 18, 2015. The Parkville location will be the first mobility dealer in America where people with disabilities can see the BraunAbility Explorer MXV Wheelchair Accessible SUV, Mobility SVM SUV Suburban and Allegiant Mobility Honda Pilot.

CEO Open Letter to Shareholders of HASCO Medical, Inc.
Marketwired - Mon Apr 06, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC)

HASCO Medical Reports Record 2014 Results
Marketwired - Mon Mar 30, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a company that conducts sales of wheelchair accessible vehicles, parts, service and rentals, reported audited results for the year ended December 31st, 2014.

Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 9.50 (+0.50), ILMN: 199.07 (+0.15), HBIO: 5.24 (-0.16), PODD: 27.01 (-0.24), IART: 66.00 (+0.04), IVC: 21.62 (+1.11), IMRS: 0.70 (-0.06), INGN: 38.54 (+0.12), IDXX: 135.24 (+1.96), HRC: 51.83 (+0.44), HOLX: 34.44 (+0.14)

HASCO Medical's Ride-Away(R) Welcomes New Wheelchair Accessible Sport Utility Vehicles
Marketwired - Wed Mar 11, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a company that conducts sales of wheelchair accessible vehicles, parts, service and rentals announces two new wheelchair accessible sport utility vehicles, the BraunAbility MXV and Mobility SVM SUV available summer 2015.

HASCO Medical's Newest Ride-Away(R) Location to Grand Open April 17th and 18th
Marketwired - Mon Mar 09, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a company that conducts sales of wheelchair accessible vans, parts, service and rentals, announces the Grand Opening of the new Parkville, Maryland Ride-Away(R) location April 17-18, 2015.

HASCO Medical Expects Record Q4 2014 Revenues of $22.7 Million, Wheelchair Van Growth Strong in 2015
Marketwired - Tue Feb 17, 7:31AM CST
HASCO Medical, Inc. (OTCQB: HASC), a leading provider of wheelchair accessible vans, parts and service, reported preliminary results for the fourth quarter ended December 31st, 2014.

HASCO Medical's Ride-Away Partners With Uber to Expand Accessible Transportation Options in Greater Washington, DC Area
Marketwired - Mon Dec 08, 7:31AM CST
Ride-Away(R), one of the largest and most trusted dealers of wheelchair accessible vehicles and subsidiary of HASCO Medical, Inc. (OTCQB: HASC), has partnered with Uber, a technology company that connects riders and drivers through a mobile app, to offer significant discounts and preferred financing rates on wheelchair accessible vehicles for Uber driver partners in the greater Washington, DC area. The partnership works to expand accessible transportation options for residents and visitors in the area by supporting the growth of drivers with wheelchair accessible vehicles.

HASCO Medical Common Stock Uplists to OTCQB
Marketwired - Tue Nov 25, 7:31AM CST
The common stock of HASCO Medical, Inc. (OTC PINK: HASC) (OTCQB: HASC), a leading provider of handicap-accessible vans, parts and service, will uplist from the OTC Pink(R) to the OTCQB(R) beginning at the opening of trading today, November 25. The ticker symbol will remain the same as "HASC."

Hasco Medical reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:41AM CST


HASCO Medical Reports Record Third Quarter 2014 Results
Marketwired - Thu Nov 13, 7:32AM CST
HASCO Medical, Inc. (PINKSHEETS: HASC), a leading provider of handicap-accessible vans, parts and service, reported results for the third quarter ended September 30, 2014.

Hasco reports preliminary Q3 revenues
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 9:48AM CDT


HASCO Medical Expects Record Third Quarter 2014 Total Net Revenues of Approximately $23.8 Million, up 22%
Marketwired - Wed Oct 22, 7:33AM CDT
HASCO Medical, Inc. (PINKSHEETS: HASC), a leading provider of handicap-accessible vans, parts and service, reported preliminary results for the third quarter ended September 30, 2014.

HASCO Medical's Ride-Away Opens New Wheelchair Accessible Vans Dealership to Service Baltimore Metro Area
Marketwired - Fri Oct 10, 7:31AM CDT
Ride-Away(R), a leading provider of handicap-accessible vans, parts and service and subsidiary of HASCO Medical, Inc. (OTCQB: HASC), will open its doors next Monday to a new mobility dealership in Parkville, Maryland that will service customers in the Baltimore metropolitan area.

HASCO Medical's We Deliver Freedom Program Helps Two Families Raise Funds for Wheelchair Accessible Vehicles
PRWeb - Wed Sep 17, 2:28AM CDT
Mobility Freedom, one of Florida's leading providers of wheelchair accessible vehicles and adaptive driving equipment and subsidiary of HASCO Medical, Inc. (OTCQB: HASC), recently celebrated two successes of its We Deliver Freedom program.

HASCO Medical Reports Record Second Quarter 2014 Results
Marketwire - Wed Sep 03, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a leading provider of handicap-accessible vans, parts and service, reported results for the second quarter ended June 30, 2014.

HASCO Medical swings to record net income of USD194,000 in Q1 2014
M2 - Thu Aug 21, 8:01AM CDT
Handicap accessible parts company HASCO Medical (OTCQB:HASC) disclosed on Wednesday its net income of USD194,000 for the first quarter ended 31 March 2014.

HASCO Medical Reports Record First Quarter 2014 Results
Marketwire - Wed Aug 20, 7:31AM CDT
HASCO Medical, Inc. (OTCQB: HASC), a leading provider of handicap-accessible vans, parts and service, reported results for the first quarter ended March 31, 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading